Women harboring BRCA1 or BRCA2 (BRCA) germline pathogenic sequence variants (PSVs) are at a substantially increased lifetime risk for developing breast cancer (BC) estimated at 72% and 69%, respectively [1], at times diagnosed at an early age—< 40 years. Here, BRCA2 is linked to breast cancer.